SRK-181 Alone or in Combination With Anti-PD-(L)1 Antibody Therapy in Patients With Locally Advanced or Metastatic Solid Tumors

Condition:   Cancer Interventions:   Biological: SRK-181;   Biological: anti-PD-(L)1 antibody therapy Sponsor:   Scholar Rock, Inc. Not yet recruiting

Source: ClinicalTrials.gov - March 2, 2020 Category: Research Source Type: clinical trials